51 – 60 of 200
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Radiotherapy for GIST progressing during or after tyrosine kinase inhibitor therapy: A prospective study.
(
- Contribution to journal › Article
-
Mark
INITIAL COMMISSIONING RESULTS OF THE MAX IV INJECTOR
2015)(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
BEAM COMMISSIONING AND INITIAL MEASUREMENTS ON THE MAX IV 3 GeV LINAC
2015)(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Referral patterns, treatment and outcome of high-grade malignant bone sarcoma in Scandinavia-SSG Central Register 25 years' experience.
(
- Contribution to journal › Article
-
Mark
Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: results from a phase 2 study by The Nordic Lymphoma Group.
(
- Contribution to journal › Article
-
Mark
Post-Relapse Survival in Patients With Ewing Sarcoma
(
- Contribution to journal › Article
-
Mark
F-18-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study
(
- Contribution to journal › Article
-
Mark
EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment.
(
- Contribution to journal › Article
-
Mark
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial
(
- Contribution to journal › Article
-
Mark
Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants
(
- Contribution to journal › Article